Evaluation of antimicrobial and antibiofilm activities of peptide Impatiens balsamina-M1 and Zinc oxide nanoparticles against Helicobacter pylori

Helicobacter pylori is a common human pathogen associated with chronic gastritis, peptic ulcers, and gastric cancer. The bacterium’s ability to form biofilms and acquire antibiotic resistance, especially against clarithromycin and metronidazole, has considerably reduced the efficacy of conventional treatment. These difficulties highlight the urgent need for new antimicrobial strategies that can disrupt biofilms and combat antibiotic resistance. Antimicrobial peptides and nanoparticles have emerged as promising options in this context. The antibacterial and antibiofilm properties of Impatiens balsamina-M1 (Ib-M1), green-synthesised Zinc Oxide nanoparticles (ZnO NPs), and their combination against H. pylori were assessed in this study, representing the assessment of their effects on biofilm formation, virulence gene expression, and host cell invasion. MIC (minimum inhibitory concentration) values confirmed stronger antibacterial activity of ZnO NPs (16–32 µg/mL) than Ib-M1 (500–1000 µg/mL). For H. pylori strain BY-1, the combination had an additive effect, while in other strains, it was indifferent. SEM demonstrated significant biofilm disruption, and biofilm assays showed lower MBEC (minimum biofilm eradication concentration) values with the combination. qRT-PCR revealed downregulation of cagA, vacA, ureA, hspR, and spoT, especially when treatments were combined. Flow cytometry showed that bacterial invasion into AGS gastric adenocarcinoma cells dropped from 21.9 (control) to 3.6% with the combination. All three treatments exhibited acceptable cytotoxicity, with the combination showing significantly less toxic effects on AGS cells. Together, these findings suggest that these antimicrobial agents provide a promising, environmentally friendly approach to combat antibiotic-resistant H. pylori, efficiently reducing host cell invasion, virulence gene expression, growth, and biofilm formation while maintaining low cytotoxicity.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-12-10
DOI
https://doi.org/10.1038/s41598-025-31310-9
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of antimicrobial and antibiofilm activities of peptide Impatiens balsamina-M1 and Zinc oxide nanoparticles against Helicobacter pylori

Abbas Yadegar, Elham Tabesh, Mohammad Kazemi, Vajihe Karbasizade et al.
Scientific Reports
Antimicrobial Peptides and Activities
article

Evaluation of antimicrobial and antibiofilm activities of peptide Impatiens balsamina-M1 and Zinc oxide nanoparticles against Helicobacter pylori

Abbas Yadegar, Elham Tabesh, Mohammad Kazemi, Vajihe Karbasizade, Mina Zolfaghari, Atefe Rezaei, Hossein Fazeli
article en

Abstract

Helicobacter pylori is a common human pathogen associated with chronic gastritis, peptic ulcers, and gastric cancer. The bacterium’s ability to form biofilms and acquire antibiotic resistance, especially against clarithromycin and metronidazole, has considerably reduced the efficacy of conventional treatment. These difficulties highlight the urgent need for new antimicrobial strategies that can disrupt biofilms and combat antibiotic resistance. Antimicrobial peptides and nanoparticles have emerged as promising options in this context. The antibacterial and antibiofilm properties of Impatiens balsamina-M1 (Ib-M1), green-synthesised Zinc Oxide nanoparticles (ZnO NPs), and their combination against H. pylori were assessed in this study, representing the assessment of their effects on biofilm formation, virulence gene expression, and host cell invasion. MIC (minimum inhibitory concentration) values confirmed stronger antibacterial activity of ZnO NPs (16–32 µg/mL) than Ib-M1 (500–1000 µg/mL). For H. pylori strain BY-1, the combination had an additive effect, while in other strains, it was indifferent. SEM demonstrated significant biofilm disruption, and biofilm assays showed lower MBEC (minimum biofilm eradication concentration) values with the combination. qRT-PCR revealed downregulation of cagA, vacA, ureA, hspR, and spoT, especially when treatments were combined. Flow cytometry showed that bacterial invasion into AGS gastric adenocarcinoma cells dropped from 21.9 (control) to 3.6% with the combination. All three treatments exhibited acceptable cytotoxicity, with the combination showing significantly less toxic effects on AGS cells. Together, these findings suggest that these antimicrobial agents provide a promising, environmentally friendly approach to combat antibiotic-resistant H. pylori, efficiently reducing host cell invasion, virulence gene expression, growth, and biofilm formation while maintaining low cytotoxicity.

Scientific ReportsVol. 16(1)
Isfahan University of Medical Sciences (IR), Shahid Beheshti University of Medical Sciences (IR), Technical University of Munich (DE)
Isfahan University of Medical Sciences, Shahid Beheshti University of Medical Sciences, Research Institute for Gastroenterology and Liver Diseases
Openalex Percentile: Top 62%
Antimicrobial Peptides and Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.